All In MedTech

FDA Clearance Tracker · P860004-S294

SynchroMed Infusion System / Ascenda Intrathecal Catheters

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 18, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 18, 2018

Approved

Time to decision

158 days

Received Dec 11, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P860004-S294
Device name
SynchroMed Infusion System / Ascenda Intrathecal Catheters
Applicant location
Minneapolis, MN
Received
Dec 11, 2017
Decided
May 18, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P860004

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

Approval for a alternate manufacturing site located at Medtronic Puerto Rico Operations Company, Junccos, Road 31, Km. 24, Hm 4, Deiba Norte Industrial Park, Juncos, PR 00777 for manufacturing and sterilization of the Ascenda Catheter and accessories.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.